Search by Drug Name or NDC
NDC 49281-0589-05 Menactra 4; 4; 4; 4 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL Details
Menactra 4; 4; 4; 4 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
Menactra is a INTRAMUSCULAR INJECTION, SOLUTION in the VACCINE category. It is labeled and distributed by Sanofi Pasteur Inc.. The primary component is NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA T.
Product Information
| NDC | 49281-0589 |
|---|---|
| Product ID | 49281-589_ebc98cee-030f-46c1-8d1b-87da533152d9 |
| Associated GPIs | 17200040452000 |
| GCN Sequence Number | 063830 |
| GCN Sequence Number Description | mening vac A,C,Y,W-135 dip/PF VIAL 4MCG/0.5ML INTRAMUSC |
| HIC3 | W7Q |
| HIC3 Description | GRAM NEGATIVE COCCI VACCINES |
| GCN | 99539 |
| HICL Sequence Number | 035486 |
| HICL Sequence Number Description | MENINGOCOCCAL VACCINE A,C,Y,W-135,DIPHTHERIA TOXOID CONJ/PF |
| Brand/Generic | Brand |
| Proprietary Name | Menactra |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOI |
| Product Type | VACCINE |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 4; 4; 4; 4 |
| Active Ingredient Units | ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
| Substance Name | NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA T |
| Labeler Name | Sanofi Pasteur Inc. |
| Pharmaceutical Class | Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Inactivated Meningococcal Vaccine [EPC], Inactivated Meningococcal Vaccine [EPC], Inactivated Meningococcal Vaccine [EPC], |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125089 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 49281-0589-05 (49281058905)
| NDC Package Code | 49281-589-05 |
|---|---|
| Billing NDC | 49281058905 |
| Package | 5 VIAL, SINGLE-DOSE in 1 PACKAGE (49281-589-05) / .5 mL in 1 VIAL, SINGLE-DOSE (49281-589-58) |
| Marketing Start Date | 2005-01-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |